LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research

...

Synthetic data trailblazer and CHEO Research Institute spin-off, Replica Analytics, acquired by Aetion signalling CHEO as a place for incubating start-ups

Aetion Acquires Synthetic Data Trailblazer Replica Analytics

European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe

FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation

Aetion and Quinten Health partner to use AI and RWE to reduce research timelines

Aetion Welcomes Marla Kessler as First Chief Customer Officer to Accelerate Its Next Phase of Growth

HumanFirst joins the FDA, HHS and more than 20 organizations and leading health companies to launch the Digital Health Measurement Collaborative Community (DATAcc)

Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence

Aetion Closes $110M Series C Funding Round Led by Warburg Pincus

  • 1
  • 2
  • 3
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • Through reverse auctions, Minnesota pushes for PBM savings and price transparency

  • Matternet Tests Longest Drone Delivery Route Between Hospitals and Labs in Switzerland

  • Matternet Set to Produce M2 Delivery Drones in the US After Receiving FAA Greenlight

  • I’m a doctor specializing in sexual health. There’s no ‘normal’ amount of sex you should be having — so you can stop worrying.

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn